Changchun Genescience Pharmaceutical Co., Ltd.

This study is testing whether a new injectable medication called GenSci120 can help control rheumatoid arthritis in people whose current treatments aren't working well enough. Researchers will compare different doses of GenSci120 against a placebo and an existing arthritis drug (…

This study is testing a new oral medication called GS3-007a for children with growth hormone deficiency. The first part aims to find a safe dose, and the second part will compare the medication's effect on growth over one year against an existing treatment. Eligible children are …

This early-stage study is testing a new oral drug, GenSci145, in people with advanced solid tumors that have a specific genetic change called a PIK3CA mutation. The main goals are to find a safe dose and see how the body processes the drug, while also looking for early signs that…

This study is testing a new injectable medicine called GenSci134 for children whose bodies don't make enough growth hormone. The first part checks the safety of single doses, and the second part compares multiple doses over 24 weeks to a standard treatment to see which helps chil…

This study is testing a new injectable drug called GenSci134 to see if it helps children with unexplained short stature grow taller. The first part checks the drug's safety and how the body processes it. The second part compares how well different doses work against an existing g…

This study aims to see if a new oral test (GS3-007a) works as well as the current standard insulin test for diagnosing adult growth hormone deficiency (AGHD). It will involve 120 people, including those suspected of having AGHD and healthy volunteers. Participants will take both …

This study is testing whether adding a drug called nanocrystalline megestrol acetate to standard liver cancer treatment can help patients who are experiencing severe, disease-related weight loss and poor appetite. The goal is to see if this combination helps people eat better and…

This is the first human study of an experimental drug called GenSci161. Researchers will give 44 healthy adults a single injection to test its safety and see how the body processes it. The study will start with low doses and carefully monitor participants for any side effects bef…

This early-stage study aims to understand how a new drug called GS1-144 is processed by the body in women with mild to moderate liver problems, compared to women with healthy livers. It will involve 24 female participants and will carefully measure the levels of the drug in their…

This early-stage study aims to test the safety and measure how the body processes a new vaginal treatment called GenSci142 for bacterial vaginosis. The trial will enroll 30 healthy Chinese women who will receive either the experimental treatment or a placebo. Researchers will mon…